182 related articles for article (PubMed ID: 33255304)
1. Solid Lipid Nanoparticles as Formulative Strategy to Increase Oral Permeation of a Molecule Active in Multidrug-Resistant Tuberculosis Management.
Obinu A; Porcu EP; Piras S; Ibba R; Carta A; Molicotti P; Migheli R; Dalpiaz A; Ferraro L; Rassu G; Gavini E; Giunchedi P
Pharmaceutics; 2020 Nov; 12(12):. PubMed ID: 33255304
[TBL] [Abstract][Full Text] [Related]
2. Improving in vivo oral bioavailability of a poorly soluble drug: a case study on polymeric versus lipid nanoparticles.
Rassu G; Obinu A; Serri C; Piras S; Carta A; Ferraro L; Gavini E; Giunchedi P; Dalpiaz A
Drug Deliv Transl Res; 2023 Apr; 13(4):1128-1139. PubMed ID: 36509967
[TBL] [Abstract][Full Text] [Related]
3. Formulation, optimization, and characterization of rifampicin-loaded solid lipid nanoparticles for the treatment of tuberculosis.
Chokshi NV; Khatri HN; Patel MM
Drug Dev Ind Pharm; 2018 Dec; 44(12):1975-1989. PubMed ID: 30058392
[TBL] [Abstract][Full Text] [Related]
4. Solid lipid nanoparticles for transdermal delivery of avanafil: optimization, formulation, in-vitro and ex-vivo studies.
Kurakula M; Ahmed OA; Fahmy UA; Ahmed TA
J Liposome Res; 2016 Dec; 26(4):288-96. PubMed ID: 26784833
[TBL] [Abstract][Full Text] [Related]
5. Paliperidone-Loaded Nanolipomer System for Sustained Delivery and Enhanced Intestinal Permeation: Superiority to Polymeric and Solid Lipid Nanoparticles.
Helal HM; Mortada SM; Sallam MA
AAPS PharmSciTech; 2017 Aug; 18(6):1946-1959. PubMed ID: 27914041
[TBL] [Abstract][Full Text] [Related]
6. Solid lipid nanoparticles containing anti-tubercular drugs attenuate the Mycobacterium marinum infection.
Khatak S; Mehta M; Awasthi R; Paudel KR; Singh SK; Gulati M; Hansbro NG; Hansbro PM; Dua K; Dureja H
Tuberculosis (Edinb); 2020 Dec; 125():102008. PubMed ID: 33059322
[TBL] [Abstract][Full Text] [Related]
7. Fabrication, appraisal, and transdermal permeation of sildenafil citrate-loaded nanostructured lipid carriers versus solid lipid nanoparticles.
Elnaggar YS; El-Massik MA; Abdallah OY
Int J Nanomedicine; 2011; 6():3195-205. PubMed ID: 22238508
[TBL] [Abstract][Full Text] [Related]
8. Lipid nanocarriers (GeluPearl) containing amphiphilic lipid Gelucire 50/13 as a novel stabilizer: fabrication, characterization and evaluation for oral drug delivery.
Date AA; Vador N; Jagtap A; Nagarsenker MS
Nanotechnology; 2011 Jul; 22(27):275102. PubMed ID: 21606564
[TBL] [Abstract][Full Text] [Related]
9. Beta-carotene-Encapsulated Solid Lipid Nanoparticles (BC-SLNs) as Promising Vehicle for Cancer: an Investigative Assessment.
Jain A; Sharma G; Thakur K; Raza K; Shivhare US; Ghoshal G; Katare OP
AAPS PharmSciTech; 2019 Feb; 20(3):100. PubMed ID: 30721373
[TBL] [Abstract][Full Text] [Related]
10. Development of vorinostat-loaded solid lipid nanoparticles to enhance pharmacokinetics and efficacy against multidrug-resistant cancer cells.
Tran TH; Ramasamy T; Truong DH; Shin BS; Choi HG; Yong CS; Kim JO
Pharm Res; 2014 Aug; 31(8):1978-88. PubMed ID: 24562809
[TBL] [Abstract][Full Text] [Related]
11. Solid Lipid Nanoparticles and Chitosan-coated Solid Lipid Nanoparticles as Promising Tool for Silybin Delivery: Formulation, Characterization, and In vitro Evaluation.
Piazzini V; Cinci L; D'Ambrosio M; Luceri C; Bilia AR; Bergonzi MC
Curr Drug Deliv; 2019; 16(2):142-152. PubMed ID: 30306869
[TBL] [Abstract][Full Text] [Related]
12. Curcumin-loaded solid lipid nanoparticles with Brij78 and TPGS improved in vivo oral bioavailability and in situ intestinal absorption of curcumin.
Ji H; Tang J; Li M; Ren J; Zheng N; Wu L
Drug Deliv; 2016; 23(2):459-70. PubMed ID: 24892628
[TBL] [Abstract][Full Text] [Related]
13. Development of mirtazapine loaded solid lipid nanoparticles for topical delivery: Optimization, characterization and cytotoxicity evaluation.
Kaur R; Sharma N; Tikoo K; Sinha VR
Int J Pharm; 2020 Aug; 586():119439. PubMed ID: 32622808
[TBL] [Abstract][Full Text] [Related]
14. Use of Lipid Nanocarriers to Improve Oral Delivery of Vitamins.
Hsu CY; Wang PW; Alalaiwe A; Lin ZC; Fang JY
Nutrients; 2019 Jan; 11(1):. PubMed ID: 30609658
[TBL] [Abstract][Full Text] [Related]
15. In-situ single pass intestinal permeability and pharmacokinetic study of developed Lumefantrine loaded solid lipid nanoparticles.
Garg A; Bhalala K; Tomar DS; Wahajuddin
Int J Pharm; 2017 Jan; 516(1-2):120-130. PubMed ID: 27989820
[TBL] [Abstract][Full Text] [Related]
16. Gastrointestinal stability, physicochemical characterization and oral bioavailability of chitosan or its derivative-modified solid lipid nanoparticles loading docetaxel.
Shi LL; Lu J; Cao Y; Liu JY; Zhang XX; Zhang H; Cui JH; Cao QR
Drug Dev Ind Pharm; 2017 May; 43(5):839-846. PubMed ID: 27487431
[TBL] [Abstract][Full Text] [Related]
17. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
18. Surface-modified solid lipid nanoparticles for oral delivery of docetaxel: enhanced intestinal absorption and lymphatic uptake.
Cho HJ; Park JW; Yoon IS; Kim DD
Int J Nanomedicine; 2014; 9():495-504. PubMed ID: 24531717
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of Antimycobacterial Activity of Rifampicin Using Mannose-Anchored Lipid Nanoparticles against Intramacrophage Mycobacteria.
Mistry N; Bandyopadhyaya R; Mehra S
ACS Appl Bio Mater; 2022 Dec; 5(12):5779-5789. PubMed ID: 36441965
[TBL] [Abstract][Full Text] [Related]
20. Primary Studies on Construction and Evaluation of Ion-Sensitive in situ Gel Loaded with Paeonol-Solid Lipid Nanoparticles for Intranasal Drug Delivery.
Sun Y; Li L; Xie H; Wang Y; Gao S; Zhang L; Bo F; Yang S; Feng A
Int J Nanomedicine; 2020; 15():3137-3160. PubMed ID: 32440115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
